OCCIDENT
Investor profile
Venture capital
Also recorded as: Occident Group
Deals
19
distinct rounds
Companies
15
backed
Active span
2016–2025
10 yrs
Total round €
€490M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- High-Tech Gründerfonds (HTGF)7
- Zürcher Kantonalbank5
- Bayern Kapital3
- Andera Partners2
- FundPlus2
- Seventure Partners2
- Arve Capital1
- Ascenta Capital1
- Beteiligungs-Managementgesellschaft Hessen (BMH)1
- BHS Corrugated1
- BioMedPartners1
- bm-t Beteiligungsmanagement Thüringen GmbH1
- CDP Venture Capital's Digital Transition Fund1
- Coparion1
- Deep Track Capital1
- Dr. Tine Tomažič1
- EGSB1
- EIC Fund1
- EQT Life Sciences1
- Evotec1
- Frazier Life Sciences1
- Hemex1
- Innovestor1
- JFG Life Sciences Foundation1
- Launchpad Capital1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Tubulis Technologies | Germany | 2 | €368M |
| Lunaphore Technologies | Switzerland | 2 | €45M |
| Lymphatica Medtech | Switzerland | 1 | €18M |
| Code Intelligence | Germany | 1 | €12M |
| resistell | Switzerland | 2 | €12M |
| Hemotune AG | Switzerland | 1 | €7.1M |
| Altavo | Germany | 1 | €5.0M |
| hemotune | Switzerland | 1 | €4.7M |
| core sensing | Germany | 1 | €4.5M |
| Invasight | Switzerland | 1 | €4.3M |
| Resistell Ag | Switzerland | 2 | €3.3M |
| Chipmetrics | Finland | 1 | €2.4M |
| Avelo | Switzerland | 1 | €2.3M |
| ReCatalyst | Slovenia | 1 | €1.7M |
| Cunesoft | Germany | 1 | €0 |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Tubulis Technologies | Series C | €308M | 2025-10 |
| Tubulis Technologies | Series B | €60M | 2022-05 |
| Lunaphore Technologies | Series D+ | €40M | 2023-03 |
| Lymphatica Medtech | Other | €18M | 2024-10 |
| Code Intelligence | Other | €12M | 2022-06 |
| resistell | Series B | €8.6M | 2022-12 |
| Hemotune AG | Series B | €7.1M | 2022-04 |
| Altavo | Series A | €5.0M | 2024-02 |
| hemotune | Series A | €4.7M | 2020-08 |
| Lunaphore Technologies | Series B | €4.6M | 2018-08 |